To date, studies on the GPX3 gene, which is a target gene of NRF2, have mainly focused on cancers, including colitis-associated carcinoma; for example, Gpx3-deficient mice exhibited increased tumor number and inflammation, suggesting a protective role of GPX3 in colitis-associated carcinoma [77]. The gene discussed is GPX3; the disease is cancer.